Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03050541Completed
Randomised, double-blind trial of midomafetamine in post-traumatic stress disorder (PTSD), sponsored by University of Chicago. Primary endpoint: Probability of Accurately Recalling Visual Stimuli at 48 hours. Started Dec 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03050541.